This inventor holds 1 USPTO granted patent. Top assignee: Nurix Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hiroko Tanaka: Innovator in CBL-B Inhibition
Introduction
Hiroko Tanaka is a prominent inventor known for her contributions to the field of medicinal chemistry. She has made significant strides in the development of compounds that target specific biological pathways. Her work is particularly focused on CBL-B inhibition, which has implications for various therapeutic applications.
Latest Patents
Hiroko Tanaka holds a patent for "3-Substituted Piperidine Compounds for CBL-B Inhibition, and Use Thereof." This patent highlights her innovative approach to creating compounds that can potentially lead to new treatments in medicine. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Tanaka is currently employed at Nurix Therapeutics, Inc., where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other talented scientists and contribute to groundbreaking projects in the pharmaceutical industry.
Collaborations
Throughout her career, Hiroko has worked alongside notable colleagues, including Mario G. Cardozo and Arthur T. Sands. These collaborations have enriched her research and expanded the impact of her work in the field.
Conclusion
Hiroko Tanaka is a dedicated inventor whose work in CBL-B inhibition is paving the way for future advancements in medicine. Her contributions are vital to the ongoing research in this area, and her innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile